Research location
Castelló
Spain
Advertisement
Research activity in Castelló
SpainCureCurrent currently publishes aggregate city-level research activity for this location: 12 trials and 12 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Castelló
12 linked trials · page 1 of 1Long-Term Follow-up Study of Early Stage Breast Cancer Patients Included in GEICAM StudiesNCT03390894 · 2018-01-18 · 1 site observation
RECRUITING
A Trial Using ARV-471 or Anastrozole in Post-Menopausal Women With Breast Cancer Prior to SurgeryNCT05549505 · 2023-02-15 · 1 site observation
COMPLETED
Screening for Cancer in Patients With Unprovoked VTENCT03937583 · 2019-10-23 · 1 site observation
UNKNOWN
Neadjuvant Multi-agent Chemotherapy or Letrozole Plus Ribociclib in Luminal B/HER2-negative Breast Cancer.NCT03248427 · 2017-07-13 · 1 site observation
COMPLETED
Analysis of Soluble Mediators,Cytokines and FACs as Prognostic Factors in Advanced Non-squamous Lung CarcinomaNCT03156868 · 2016-08-03 · 1 site observation
COMPLETED
Palbociclib in Combination With Fulvestrant or Letrozole in Patients With ER+, HER2- Advanced Breast CancerNCT02491983 · 2015-08-01 · 1 site observation
COMPLETED
OPTimizing Irradiation Through Molecular Assessment of Lymph Node (OPTIMAL)NCT02335957 · 2015-04-01 · 1 site observation
COMPLETED
Survival imProvement in Lung cancEr iNduced by DenOsUmab theRapyNCT02129699 · 2015-01-06 · 1 site observation
TERMINATED
A Randomized Study of AZD2014 in Combination With Fulvestrant in Metastatic or Advanced Breast CancerNCT02216786 · 2014-01-16 · 1 site observation
COMPLETED
Schedules of Nab-Paclitaxel in Metastatic Breast CancerNCT01746225 · 2013-04-01 · 1 site observation
COMPLETED
Study to Evaluate Treatment Customized According to RAP80 and BRCA1 in Patients With Advanced Lung CarcinomaNCT00617656 · 2008-02-01 · 1 site observation
TERMINATED
Caelyx, Cyclophosphamide and Herceptin in Patients With Metastatic Breast CancerNCT00258960 · 2006-02-15 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.